WEBVTT
Kind: captions
Language: en

00:00:00.469 --> 00:00:03.080 

good<00:00:01.469> morning<00:00:01.920> I'll<00:00:02.220> present<00:00:02.490> earlier

00:00:03.080 --> 00:00:03.090 
good morning I'll present earlier

00:00:03.090 --> 00:00:06.110 
good morning I'll present earlier
results<00:00:03.629> of<00:00:03.840> micro<00:00:04.410> drilling<00:00:04.920> surgery<00:00:05.520> for

00:00:06.110 --> 00:00:06.120 
results of micro drilling surgery for

00:00:06.120 --> 00:00:08.000 
results of micro drilling surgery for
full<00:00:06.390> thickness<00:00:06.720> control<00:00:07.140> lesions<00:00:07.770> of<00:00:07.950> the

00:00:08.000 --> 00:00:08.010 
full thickness control lesions of the

00:00:08.010 --> 00:00:10.790 
full thickness control lesions of the
knee<00:00:08.450> augmented<00:00:09.450> with<00:00:09.630> concentrated<00:00:10.440> bone

00:00:10.790 --> 00:00:10.800 
knee augmented with concentrated bone

00:00:10.800 --> 00:00:13.520 
knee augmented with concentrated bone
marrow<00:00:11.130> aspirate<00:00:11.759> platelet-rich<00:00:12.630> plasma<00:00:12.840> and

00:00:13.520 --> 00:00:13.530 
marrow aspirate platelet-rich plasma and

00:00:13.530 --> 00:00:18.260 
marrow aspirate platelet-rich plasma and
hyaluronic<00:00:14.009> acid<00:00:14.880> my<00:00:16.369> co-author<00:00:17.369> and<00:00:17.609> I<00:00:17.970> have

00:00:18.260 --> 00:00:18.270 
hyaluronic acid my co-author and I have

00:00:18.270 --> 00:00:21.620 
hyaluronic acid my co-author and I have
no<00:00:18.510> disclosures<00:00:19.970> full<00:00:20.970> thickness<00:00:21.240> control

00:00:21.620 --> 00:00:21.630 
no disclosures full thickness control

00:00:21.630 --> 00:00:24.109 
no disclosures full thickness control
lesions<00:00:22.230> of<00:00:22.410> the<00:00:22.470> knee<00:00:22.710> can<00:00:23.189> be<00:00:23.340> a<00:00:23.369> significant

00:00:24.109 --> 00:00:24.119 
lesions of the knee can be a significant

00:00:24.119 --> 00:00:26.750 
lesions of the knee can be a significant
source<00:00:24.359> of<00:00:24.660> pain<00:00:25.160> existing<00:00:26.160> treatments

00:00:26.750 --> 00:00:26.760 
source of pain existing treatments

00:00:26.760 --> 00:00:31.700 
source of pain existing treatments
though<00:00:26.939> primarily<00:00:27.359> formed<00:00:28.019> fibrocartilage

00:00:31.700 --> 00:00:31.710 

00:00:31.710 --> 00:00:34.710 

the<00:00:32.710> big<00:00:32.890> problem<00:00:33.430> with<00:00:33.640> standard<00:00:34.150> treatments

00:00:34.710 --> 00:00:34.720 
the big problem with standard treatments

00:00:34.720 --> 00:00:37.260 
the big problem with standard treatments
is<00:00:34.930> they<00:00:35.260> don't<00:00:35.530> work<00:00:35.830> well<00:00:36.100> for<00:00:36.400> bipolar<00:00:36.880> or

00:00:37.260 --> 00:00:37.270 
is they don't work well for bipolar or

00:00:37.270 --> 00:00:40.410 
is they don't work well for bipolar or
kissing<00:00:37.840> lesions<00:00:38.320> the<00:00:39.280> best<00:00:39.520> solution<00:00:40.060> if<00:00:40.239> it

00:00:40.410 --> 00:00:40.420 
kissing lesions the best solution if it

00:00:40.420 --> 00:00:42.479 
kissing lesions the best solution if it
existed<00:00:40.989> would<00:00:41.290> be<00:00:41.470> to<00:00:41.590> just<00:00:41.800> grow<00:00:42.070> some<00:00:42.340> new

00:00:42.479 --> 00:00:42.489 
existed would be to just grow some new

00:00:42.489 --> 00:00:46.050 
existed would be to just grow some new
cartilage<00:00:44.460> what<00:00:45.460> do<00:00:45.520> you<00:00:45.610> do<00:00:45.730> for<00:00:45.970> this

00:00:46.050 --> 00:00:46.060 
cartilage what do you do for this

00:00:46.060 --> 00:00:48.869 
cartilage what do you do for this
patient<00:00:46.390> she<00:00:47.230> has<00:00:47.320> large<00:00:47.590> kissing<00:00:48.250> lesions<00:00:48.700> on

00:00:48.869 --> 00:00:48.879 
patient she has large kissing lesions on

00:00:48.879 --> 00:00:51.600 
patient she has large kissing lesions on
the<00:00:49.000> patella<00:00:49.360> inter<00:00:49.870> alia<00:00:50.200> as<00:00:50.470> well<00:00:51.220> as<00:00:51.400> the

00:00:51.600 --> 00:00:51.610 
the patella inter alia as well as the

00:00:51.610 --> 00:00:55.329 
the patella inter alia as well as the
lateral<00:00:51.940> condyle<00:00:52.510> and<00:00:52.840> tibia

00:00:55.329 --> 00:00:55.339 

00:00:55.339 --> 00:00:59.599 

in<00:00:56.539> 2011<00:00:57.539> doctors<00:00:58.260> saw<00:00:58.710> an<00:00:59.010> associates

00:00:59.599 --> 00:00:59.609 
in 2011 doctors saw an associates

00:00:59.609 --> 00:01:01.729 
in 2011 doctors saw an associates
published<00:01:00.089> a<00:01:00.239> series<00:01:00.480> of<00:01:00.659> five<00:01:01.050> patients

00:01:01.729 --> 00:01:01.739 
published a series of five patients

00:01:01.739 --> 00:01:04.240 
published a series of five patients
treated<00:01:02.519> with<00:01:02.550> micro<00:01:03.030> drilling<00:01:03.420> surgery<00:01:03.929> and

00:01:04.240 --> 00:01:04.250 
treated with micro drilling surgery and

00:01:04.250 --> 00:01:06.830 
treated with micro drilling surgery and
post-operative<00:01:05.250> injections<00:01:06.060> of<00:01:06.240> peripheral

00:01:06.830 --> 00:01:06.840 
post-operative injections of peripheral

00:01:06.840 --> 00:01:09.469 
post-operative injections of peripheral
blood<00:01:06.990> progenitor<00:01:07.619> cells<00:01:08.220> and<00:01:08.549> hyaluronic

00:01:09.469 --> 00:01:09.479 
blood progenitor cells and hyaluronic

00:01:09.479 --> 00:01:13.429 
blood progenitor cells and hyaluronic
acid<00:01:10.759> second-look<00:01:11.759> biopsy<00:01:12.570> confirmed<00:01:13.110> the

00:01:13.429 --> 00:01:13.439 
acid second-look biopsy confirmed the

00:01:13.439 --> 00:01:16.179 
acid second-look biopsy confirmed the
presence<00:01:13.710> of<00:01:14.039> type<00:01:14.610> 2<00:01:14.820> collagen<00:01:15.479> in

00:01:16.179 --> 00:01:16.189 
presence of type 2 collagen in

00:01:16.189 --> 00:01:22.190 
presence of type 2 collagen in
proteoglycans<00:01:19.729> this<00:01:20.729> 49<00:01:21.299> year<00:01:21.570> old<00:01:21.689> patient

00:01:22.190 --> 00:01:22.200 
proteoglycans this 49 year old patient

00:01:22.200 --> 00:01:25.130 
proteoglycans this 49 year old patient
had<00:01:22.439> a<00:01:22.470> varus<00:01:22.950> deformity<00:01:22.979> and<00:01:23.850> also<00:01:24.600> required

00:01:25.130 --> 00:01:25.140 
had a varus deformity and also required

00:01:25.140 --> 00:01:28.490 
had a varus deformity and also required
a<00:01:25.350> proximal<00:01:25.979> tibia<00:01:26.399> osteotomy<00:01:27.360> the<00:01:28.080> medial

00:01:28.490 --> 00:01:28.500 
a proximal tibia osteotomy the medial

00:01:28.500 --> 00:01:32.919 
a proximal tibia osteotomy the medial
joint<00:01:28.830> space<00:01:29.159> is<00:01:29.490> improved<00:01:30.060> at<00:01:30.360> 18<00:01:30.780> months

00:01:32.919 --> 00:01:32.929 
joint space is improved at 18 months

00:01:32.929 --> 00:01:36.309 
joint space is improved at 18 months
biopsy<00:01:33.929> is<00:01:34.110> the<00:01:34.259> medial<00:01:34.679> condyle<00:01:35.280> and<00:01:35.610> tibia

00:01:36.309 --> 00:01:36.319 
biopsy is the medial condyle and tibia

00:01:36.319 --> 00:01:38.809 
biopsy is the medial condyle and tibia
demonstrated<00:01:37.319> characteristics<00:01:38.190> of<00:01:38.399> hyaline

00:01:38.809 --> 00:01:38.819 
demonstrated characteristics of hyaline

00:01:38.819 --> 00:01:42.180 
demonstrated characteristics of hyaline
cartilage

00:01:42.180 --> 00:01:42.190 

00:01:42.190 --> 00:01:44.950 

another<00:01:43.190> 34<00:01:43.850> year<00:01:44.060> old<00:01:44.180> patient<00:01:44.420> had

00:01:44.950 --> 00:01:44.960 
another 34 year old patient had

00:01:44.960 --> 00:01:47.020 
another 34 year old patient had
restoration<00:01:45.770> of<00:01:45.890> her<00:01:46.070> lateral<00:01:46.580> patella

00:01:47.020 --> 00:01:47.030 
restoration of her lateral patella

00:01:47.030 --> 00:01:50.560 
restoration of her lateral patella
femoral<00:01:47.350> articulation<00:01:48.350> by<00:01:48.530> two<00:01:48.590> years<00:01:49.570> biopsy

00:01:50.560 --> 00:01:50.570 
femoral articulation by two years biopsy

00:01:50.570 --> 00:01:52.899 
femoral articulation by two years biopsy
of<00:01:50.720> her<00:01:50.900> cartilage<00:01:51.320> also<00:01:52.010> showed<00:01:52.340> type<00:01:52.670> 2

00:01:52.899 --> 00:01:52.909 
of her cartilage also showed type 2

00:01:52.909 --> 00:01:58.600 
of her cartilage also showed type 2
collagen<00:01:53.570> and<00:01:53.720> proteoglycans<00:01:56.979> our<00:01:57.979> treatment

00:01:58.600 --> 00:01:58.610 
collagen and proteoglycans our treatment

00:01:58.610 --> 00:02:00.910 
collagen and proteoglycans our treatment
protocol<00:01:59.119> consisted<00:01:59.869> of<00:01:59.990> micro<00:02:00.470> drilling

00:02:00.910 --> 00:02:00.920 
protocol consisted of micro drilling

00:02:00.920 --> 00:02:03.760 
protocol consisted of micro drilling
surgery<00:02:01.399> followed<00:02:02.300> by<00:02:02.450> post-op<00:02:03.050> injections

00:02:03.760 --> 00:02:03.770 
surgery followed by post-op injections

00:02:03.770 --> 00:02:05.889 
surgery followed by post-op injections
of<00:02:03.979> bone<00:02:04.250> marrow<00:02:04.580> aspirate<00:02:05.180> concentrate

00:02:05.889 --> 00:02:05.899 
of bone marrow aspirate concentrate

00:02:05.899 --> 00:02:09.389 
of bone marrow aspirate concentrate
platelet-rich<00:02:06.830> plasma<00:02:07.040> and<00:02:07.850> hyaluronic<00:02:08.360> acid

00:02:09.389 --> 00:02:09.399 
platelet-rich plasma and hyaluronic acid

00:02:09.399 --> 00:02:11.890 
platelet-rich plasma and hyaluronic acid
patients<00:02:10.399> were<00:02:10.550> partial<00:02:11.150> weight<00:02:11.330> bearing<00:02:11.360> and

00:02:11.890 --> 00:02:11.900 
patients were partial weight bearing and

00:02:11.900 --> 00:02:17.110 
patients were partial weight bearing and
used<00:02:12.680> a<00:02:12.860> CPM<00:02:15.190> bone<00:02:16.190> marrow<00:02:16.550> aspirate

00:02:17.110 --> 00:02:17.120 
used a CPM bone marrow aspirate

00:02:17.120 --> 00:02:19.300 
used a CPM bone marrow aspirate
concentrate<00:02:17.840> supplies<00:02:18.470> the<00:02:18.769> cellular

00:02:19.300 --> 00:02:19.310 
concentrate supplies the cellular

00:02:19.310 --> 00:02:22.960 
concentrate supplies the cellular
element<00:02:20.739> PRP<00:02:21.739> has<00:02:21.980> been<00:02:22.220> shown<00:02:22.489> to<00:02:22.519> promote

00:02:22.960 --> 00:02:22.970 
element PRP has been shown to promote

00:02:22.970 --> 00:02:25.479 
element PRP has been shown to promote
mesenchymal<00:02:23.840> stem<00:02:24.230> cell<00:02:24.680> differentiation

00:02:25.479 --> 00:02:25.489 
mesenchymal stem cell differentiation

00:02:25.489 --> 00:02:28.780 
mesenchymal stem cell differentiation
into<00:02:26.060> chondrocytes<00:02:26.690> and<00:02:27.310> hyaluronic<00:02:28.310> acid

00:02:28.780 --> 00:02:28.790 
into chondrocytes and hyaluronic acid

00:02:28.790 --> 00:02:32.979 
into chondrocytes and hyaluronic acid
enhances<00:02:29.420> the<00:02:29.600> proteoglycan<00:02:30.530> content<00:02:31.989> major

00:02:32.979 --> 00:02:32.989 
enhances the proteoglycan content major

00:02:32.989 --> 00:02:37.210 
enhances the proteoglycan content major
inclusion<00:02:33.860> criteria<00:02:34.040> were<00:02:35.000> age<00:02:35.300> 18<00:02:35.930> to<00:02:36.170> 64<00:02:36.890> and

00:02:37.210 --> 00:02:37.220 
inclusion criteria were age 18 to 64 and

00:02:37.220 --> 00:02:42.100 
inclusion criteria were age 18 to 64 and
a<00:02:37.820> BMI<00:02:38.540> less<00:02:38.930> than<00:02:39.170> 35<00:02:39.709> total<00:02:40.640> lesion<00:02:41.269> area<00:02:41.660> was

00:02:42.100 --> 00:02:42.110 
a BMI less than 35 total lesion area was

00:02:42.110 --> 00:02:48.130 
a BMI less than 35 total lesion area was
up<00:02:42.380> to<00:02:42.560> 18<00:02:43.100> square<00:02:43.550> centimeters

00:02:48.130 --> 00:02:48.140 

00:02:48.140 --> 00:02:51.380 

primary<00:02:49.140> outcome<00:02:49.710> measures<00:02:50.250> were<00:02:50.610> i<00:02:50.880> KDC

00:02:51.380 --> 00:02:51.390 
primary outcome measures were i KDC

00:02:51.390 --> 00:02:55.130 
primary outcome measures were i KDC
score<00:02:51.990> in<00:02:52.260> knee<00:02:52.530> Society<00:02:53.190> score<00:02:53.550> all<00:02:54.420> patients

00:02:55.130 --> 00:02:55.140 
score in knee Society score all patients

00:02:55.140 --> 00:03:00.260 
score in knee Society score all patients
get<00:02:55.410> 82<00:02:56.070> mapped<00:02:56.370> MRI<00:02:57.000> at<00:02:57.420> 18<00:02:58.050> months<00:02:59.210> this<00:03:00.210> is

00:03:00.260 --> 00:03:00.270 
get 82 mapped MRI at 18 months this is

00:03:00.270 --> 00:03:02.660 
get 82 mapped MRI at 18 months this is
an<00:03:00.630> operative<00:03:01.140> video<00:03:01.470> of<00:03:01.740> that<00:03:01.920> 18<00:03:02.310> year<00:03:02.520> old

00:03:02.660 --> 00:03:02.670 
an operative video of that 18 year old

00:03:02.670 --> 00:03:05.930 
an operative video of that 18 year old
female<00:03:03.210> shown<00:03:03.600> earlier<00:03:04.220> this<00:03:05.220> is<00:03:05.280> her<00:03:05.520> patella

00:03:05.930 --> 00:03:05.940 
female shown earlier this is her patella

00:03:05.940 --> 00:03:10.880 
female shown earlier this is her patella
femoral<00:03:06.210> compartment<00:03:08.930> lateral<00:03:09.930> condyle<00:03:10.530> and

00:03:10.880 --> 00:03:10.890 
femoral compartment lateral condyle and

00:03:10.890 --> 00:03:14.870 
femoral compartment lateral condyle and
tibia<00:03:11.340> plateau<00:03:13.190> drilling<00:03:14.190> of<00:03:14.340> the<00:03:14.460> patella

00:03:14.870 --> 00:03:14.880 
tibia plateau drilling of the patella

00:03:14.880 --> 00:03:27.800 
tibia plateau drilling of the patella
and<00:03:15.060> the<00:03:16.790> lesions<00:03:17.790> after<00:03:18.330> drilling<00:03:26.810> 16

00:03:27.800 --> 00:03:27.810 
and the lesions after drilling 16

00:03:27.810 --> 00:03:30.590 
and the lesions after drilling 16
patients<00:03:28.410> have<00:03:28.590> been<00:03:28.830> treated<00:03:29.370> to<00:03:29.400> date<00:03:29.760> the

00:03:30.590 --> 00:03:30.600 
patients have been treated to date the

00:03:30.600 --> 00:03:34.400 
patients have been treated to date the
total<00:03:31.050> area<00:03:31.260> treated<00:03:31.950> was<00:03:32.570> 0.6<00:03:33.570> to<00:03:33.870> fourteen

00:03:34.400 --> 00:03:34.410 
total area treated was 0.6 to fourteen

00:03:34.410 --> 00:03:37.130 
total area treated was 0.6 to fourteen
point<00:03:34.710> seven<00:03:34.980> square<00:03:35.460> centimeters<00:03:36.150> 12

00:03:37.130 --> 00:03:37.140 
point seven square centimeters 12

00:03:37.140 --> 00:03:38.960 
point seven square centimeters 12
patients<00:03:37.440> have<00:03:37.860> at<00:03:37.980> least<00:03:38.190> six<00:03:38.760> months

00:03:38.960 --> 00:03:38.970 
patients have at least six months

00:03:38.970 --> 00:03:42.320 
patients have at least six months
follow-up<00:03:39.630> their<00:03:40.500> eye<00:03:40.530> KDC<00:03:41.190> and<00:03:41.640> knee<00:03:41.790> Society

00:03:42.320 --> 00:03:42.330 
follow-up their eye KDC and knee Society

00:03:42.330 --> 00:03:45.260 
follow-up their eye KDC and knee Society
scores<00:03:42.690> have<00:03:42.990> improved<00:03:43.170> by<00:03:44.160> an<00:03:44.310> average<00:03:44.520> of<00:03:44.880> 22

00:03:45.260 --> 00:03:45.270 
scores have improved by an average of 22

00:03:45.270 --> 00:03:48.920 
scores have improved by an average of 22
points<00:03:45.870> and<00:03:46.050> 25<00:03:46.620> points<00:03:47.070> respectively<00:03:47.780> ten<00:03:48.780> of

00:03:48.920 --> 00:03:48.930 
points and 25 points respectively ten of

00:03:48.930 --> 00:03:50.990 
points and 25 points respectively ten of
these<00:03:49.050> 12<00:03:49.410> patients<00:03:49.950> have<00:03:50.130> improved<00:03:50.280> by<00:03:50.790> at

00:03:50.990 --> 00:03:51.000 
these 12 patients have improved by at

00:03:51.000 --> 00:03:53.660 
these 12 patients have improved by at
least<00:03:51.210> eleven<00:03:51.780> point<00:03:52.020> five<00:03:52.260> points<00:03:52.830> which<00:03:53.460> has

00:03:53.660 --> 00:03:53.670 
least eleven point five points which has

00:03:53.670 --> 00:03:55.790 
least eleven point five points which has
been<00:03:53.910> previously<00:03:54.240> shown<00:03:54.870> to<00:03:55.080> be<00:03:55.230> the<00:03:55.380> minimum

00:03:55.790 --> 00:03:55.800 
been previously shown to be the minimum

00:03:55.800 --> 00:04:00.290 
been previously shown to be the minimum
clinically<00:03:56.490> important<00:03:57.060> change<00:03:58.850> this<00:03:59.850> graph

00:04:00.290 --> 00:04:00.300 
clinically important change this graph

00:04:00.300 --> 00:04:02.630 
clinically important change this graph
shows<00:04:00.570> the<00:04:00.600> results<00:04:01.260> of<00:04:01.380> all<00:04:01.560> patients<00:04:02.190> with<00:04:02.610> a

00:04:02.630 --> 00:04:02.640 
shows the results of all patients with a

00:04:02.640 --> 00:04:06.410 
shows the results of all patients with a
95%<00:04:03.450> confidence<00:04:03.750> interval<00:04:04.440> bars<00:04:05.150> the<00:04:06.150> bars

00:04:06.410 --> 00:04:06.420 
95% confidence interval bars the bars

00:04:06.420 --> 00:04:08.900 
95% confidence interval bars the bars
are<00:04:06.660> much<00:04:06.870> larger<00:04:07.470> at<00:04:07.650> 8<00:04:07.890> to<00:04:08.100> 18<00:04:08.490> months

00:04:08.900 --> 00:04:08.910 
are much larger at 8 to 18 months

00:04:08.910 --> 00:04:11.060 
are much larger at 8 to 18 months
because<00:04:09.690> of<00:04:09.870> the<00:04:09.990> small<00:04:10.290> number<00:04:10.710> of<00:04:10.740> patients

00:04:11.060 --> 00:04:11.070 
because of the small number of patients

00:04:11.070 --> 00:04:16.070 
because of the small number of patients
that<00:04:11.460> far<00:04:11.910> out<00:04:13.640> this<00:04:14.640> is<00:04:14.850> the<00:04:15.090> same<00:04:15.330> patient<00:04:15.930> we

00:04:16.070 --> 00:04:16.080 
that far out this is the same patient we

00:04:16.080 --> 00:04:19.610 
that far out this is the same patient we
saw<00:04:16.290> earlier<00:04:16.770> with<00:04:17.489> sagittal<00:04:18.150> MRI<00:04:18.660> at<00:04:19.080> various

00:04:19.610 --> 00:04:19.620 
saw earlier with sagittal MRI at various

00:04:19.620 --> 00:04:23.210 
saw earlier with sagittal MRI at various
time<00:04:19.920> points<00:04:20.270> by<00:04:21.270> 18<00:04:21.780> months<00:04:22.220> cartilage

00:04:23.210 --> 00:04:23.220 
time points by 18 months cartilage

00:04:23.220 --> 00:04:25.340 
time points by 18 months cartilage
thickness<00:04:23.700> in<00:04:23.880> the<00:04:23.970> treated<00:04:24.420> area<00:04:24.750> is<00:04:25.020> similar

00:04:25.340 --> 00:04:25.350 
thickness in the treated area is similar

00:04:25.350 --> 00:04:28.970 
thickness in the treated area is similar
to<00:04:25.740> her<00:04:25.920> native<00:04:26.100> cartilage<00:04:27.170> t2<00:04:28.170> mapping<00:04:28.710> shows

00:04:28.970 --> 00:04:28.980 
to her native cartilage t2 mapping shows

00:04:28.980 --> 00:04:31.190 
to her native cartilage t2 mapping shows
layering<00:04:29.640> similar<00:04:30.120> to<00:04:30.360> adjacent<00:04:30.930> areas

00:04:31.190 --> 00:04:31.200 
layering similar to adjacent areas

00:04:31.200 --> 00:04:34.190 
layering similar to adjacent areas
without<00:04:32.030> biopsy<00:04:33.030> I<00:04:33.210> can't<00:04:33.570> say<00:04:33.780> of<00:04:33.930> course

00:04:34.190 --> 00:04:34.200 
without biopsy I can't say of course

00:04:34.200 --> 00:04:37.520 
without biopsy I can't say of course
what<00:04:34.440> type<00:04:34.650> of<00:04:34.860> cartilage<00:04:35.220> it<00:04:35.520> is<00:04:36.530> in

00:04:37.520 --> 00:04:37.530 
what type of cartilage it is in

00:04:37.530 --> 00:04:40.250 
what type of cartilage it is in
conclusion<00:04:38.490> early<00:04:39.030> results<00:04:39.210> are<00:04:39.540> encouraging

00:04:40.250 --> 00:04:40.260 
conclusion early results are encouraging

00:04:40.260 --> 00:04:42.350 
conclusion early results are encouraging
and<00:04:40.410> warrant<00:04:41.100> enrollment<00:04:41.670> of<00:04:41.820> additional

00:04:42.350 --> 00:04:42.360 
and warrant enrollment of additional

00:04:42.360 --> 00:04:47.770 
and warrant enrollment of additional
patients

00:04:47.770 --> 00:04:47.780 

00:04:47.780 --> 00:04:50.990 

thank<00:04:48.780> you

